CSIMarket
 

Kymera Therapeutics Inc   (KYMR)
Other Ticker:  
 

Kymera Therapeutics Inc 's Working Capital Per Sales

KYMR's Working Capital and Revenue growth



KYMR Working Capital Per Revenue (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Working Capital Change 35.23 % 17.65 % 41.71 % 81.82 % -
Y / Y Revenue Change -48.43 % -38.43 % - 39.93 % -
Working Capital Per Revenue 8.66 6.86 5.92 8.54 8.31
Total Ranking # 2114 # 2956 # 2914 # # 2831
Seq. Working Capital Change 22.17 % -7.14 % -21.51 % 51.85 % 6.29 %
Seq. Revenue Change -17.05 % 19.66 % -52.68 % 9.81 % -0.98 %


Working Capital Per Revenue Comment
Company's Working Capital Per Revenue sequentially grew to 8.66, above company average. Due to increase of revenue year on year by -48.43%.

Within Healthcare sector 460 other companies have achieved lower Working Capital Per Revenue. While Total ranking has impoved so far to 2114, from total ranking in previous quarter at 2956.
Working Capital Per Revenue Ranking
Within: No.
Industry # 112
Sector # 461
S&P 500 # 2111


Working Capital Per Revenue Statistics
High Average Low
7.4
6.05
4.76
(Sep 30 2022)   (Mar 31 2022)



Financial Statements
Kymera Therapeutics Inc 's Working Capital $ 462 Millions Visit KYMR's Balance sheet
Kymera Therapeutics Inc 's Revenues $ 10 Millions Visit KYMR's Income Statement
Where are KYMR's Sales coming from? Visit KYMR's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2022, within Healthcare Sector Working Capital Per Revenue
Foghorn Therapeutics Inc   23.28 
Scynexis Inc   23.04 
Hyperfine Inc   22.58 
Pliant Therapeutics Inc   21.88 
Infinity Pharmaceuticals Inc   20.60 
Yield10 Bioscience inc   20.41 
Wave Life Sciences Ltd   19.61 
Lyell Immunopharma Inc   19.32 
Invo Bioscience Inc   19.15 
India Globalization Capital Inc   18.99 
Fulcrum Therapeutics Inc   17.59 
Revolution Medicines Inc   17.18 
Editas Medicine inc   16.87 
Maxcyte inc   16.80 
Recursion Pharmaceuticals Inc   16.29 
Rewalk Robotics Ltd   15.91 
Dbv Technologies S a   15.81 
Predictive Oncology Inc   15.47 
Mersana Therapeutics inc   14.77 
Ispecimen inc   14.44 
Adaptimmune Therapeutics Plc  14.39 
Asensus Surgical Inc   14.30 
Acelrx Pharmaceuticals Inc  14.13 
Zomedica Corp   13.80 
Aligos Therapeutics Inc   13.38 
Seres Therapeutics Inc   12.87 
Isoplexis Corporation  12.66 
Dermtech Inc   12.37 
Aadi Bioscience Inc   12.24 
Aeglea Biotherapeutics Inc   12.07 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GEG's Profile

Stock Price

GEG's Financials

Business Description

Fundamentals

Charts & Quotes

GEG's News

Suppliers

GEG's Competitors

Customers & Markets

Economic Indicators

GEG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071